A new study led by researchers at the Harvard Pilgrim Health Care Institute has found that a 2019 Medicare opioid safety policy showed initial reductions in opioid prescribing to high-risk populations. However, the policy’s effectiveness diminished over time.
This article was originally published on MedicalXpress.com